neostigmine has been researched along with Disease Exacerbation in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gotkine, M | 1 |
| Marc, G | 1 |
| Rozenstein, L | 1 |
| Leah, R | 1 |
| Einstein, O | 1 |
| Ofira, E | 1 |
| Abramsky, O | 1 |
| Oded, A | 1 |
| Argov, Z | 1 |
| Zohar, A | 1 |
| Rosenmann, H | 1 |
| Hanna, R | 1 |
1 other study available for neostigmine and Disease Exacerbation
| Article | Year |
|---|---|
Presymptomatic treatment with acetylcholinesterase antisense oligonucleotides prolongs survival in ALS (G93A-SOD1) mice.
Topics: Acetylcholinesterase; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Disease Progre | 2013 |